Aprile C, Saponaro R, Villa G, Lunghi F
Nuklearmedizin. 1984 Feb;23(1):22-6.
Aprotinin (A) and DMSA labelled with 99mTc were compared in patients with normal (NK, n = 12) and diseased kidneys (CRF, n = 13) by means of quantitative serial scans and measurements of blood clearance and urinary excretion. Serial scans only were obtained in additional 13 patients. Scan quality in the NK patients was essentially equal: faster blood clearances, reduced urinary excretions and higher fixations of A in the target compensated for the increased liver uptake. On the other hand, the scan quality in the CRF patients was definitely superior with A, allowing detection of residual functioning parenchyma also in severe kidney failure. Correlation between the net kidney uptake 6 hrs p.i. and the separate hippuran clearance rate was better with A than with DMSA, indicating the feasibility of A in evaluating relative renal function.
通过定量连续扫描以及血清除率和尿排泄量的测量,对正常肾脏患者(NK,n = 12)和患病肾脏患者(慢性肾衰竭,CRF,n = 13)使用抑肽酶(A)和用99mTc标记的二巯基丁二酸(DMSA)进行了比较。另外13名患者仅进行了连续扫描。NK患者的扫描质量基本相同:血清除速度更快、尿排泄减少以及靶器官中A的摄取更高,弥补了肝脏摄取增加的影响。另一方面,CRF患者使用A时的扫描质量明显更优,即使在严重肾衰竭时也能检测到残余的有功能实质。注射后6小时肾脏的净摄取量与单独的马尿酸清除率之间的相关性,使用A时比使用DMSA时更好,这表明A在评估相对肾功能方面具有可行性。